Interestingly, S100A2 expression was more commonly observed in breast cancer tissues compared to normal tissues, suggesting that this expression might serve as a cancer indicator in patients who demonstrated a substantial negative correlation between ESR1 and S100A2 expression in Luminal A and Luminal B breast cancer patients. This evidence concerns the gene S100A2 and cancer.